scholarly journals LGBTQ+ Family Expansion in the Age of COVID-19: A Brief Report

2021 ◽  
pp. LGBTQ-2020-0046
Author(s):  
Penny Harvey ◽  
Natalie Ingraham

LGBTQ+ people face many barriers when trying to expand their families. The COVID-19 crisis has exacerbated existing structural barriers. In this report, we detail several existing structural barriers to reproduction that LGBTQ+ people face, highlight how those barriers are worsened by COVID-19, and suggest solutions to these barriers. We bring into conversation existing literature on family expansion and fertility treatment access for LGBTQ+ people, and situate it in the context of the current global pandemic. We argue that reproductive medicine is an essential service for LGBTQ+ people and that legislators, medical societies, and medical professionals should prioritize removing existing barriers and addressing new COVID-related ones.

Author(s):  
Harsimrat Kaur ◽  
Ram Dayal ◽  
Kamla Singh

What exactly does an embryologist do? is one of the most common question asked by patients and the possible answer could be that embryologist is the child’s first watchperson. The ability to grow embryos in laboratory environment was a huge scientific achievement. Scientists and Embryologists are involved in reproductive research and fertility treatment. The embryologist has a huge role to play in IVF/ICSI process and the contribution of embryologist is no less than infertility consultant. They might not be doctors, but they are highly trained medical professionals, holding a master’s degree or Ph.D. due to specialized nature of work. They are responsible for management and maintenance of laboratory used in creating embryos as well as monitoring those embryos. The important activities that embryologist does are maintaining the embryology lab (temperature, humidity, CO2 cylinder, diffusion gas and pH), oocyte screening during ovum pickup (OPU), incubation and checking of fertilization, embryo transfer, vitrification and embryo biopsy for pre-implantation genetic screening (PGS) or pre-implantation genetic diagnosis (PGD).


2020 ◽  
Vol 3 (2) ◽  
pp. 1-16
Author(s):  
Snjezana Zidovec Lepej ◽  
Dijana Skoric ◽  
Petra Simicic ◽  
Leona Radmanic ◽  
Suzana Harabajsa ◽  
...  

Since the first description of patients with pneumonia of unknown origin in Wuhan in December 2019, unprecedented efforts of the international scientific community led to the identification and molecular characterization of its etiological agent, e.g. SARS-CoV-2. The global pandemic of COVID-19 represents an outstanding challenge for the scientists and medical professionals worldwide. In this review, we discuss the most important aspects of SARS-CoV-2 biology and virology including antiviral and immunomodulatory treatment strategies as well as vaccine development.


2021 ◽  
pp. 135910532199971
Author(s):  
Anna Tippett

In March 2020, fertility clinics across the UK began cancelling all assisted reproductive technology (ART) treatment, with the Human Fertilisation and Embryology Authority (HFEA) stopping all ART treatment from going ahead beyond the 15th April 2020 due to the COVID-19 pandemic. This article examines the coping mechanisms adopted by fertility patients during this time, focussing on the emotional support received from online fertility forums and fertility clinics during the indeterminate wait for treatment to resume. The study draws upon an online survey which assessed the mental health and wellbeing of 124 female fertility patients whose ART treatment was cancelled due to the Coronavirus pandemic. The findings indicate a potential for improved communication between fertility clinics and patients in order to reduce psychological stress and isolation during the postponement of ART treatment, alongside better utilisation of online platforms as mechanisms for support. This article adds to the growing body of knowledge concerned with the implications of denying reproductive rights to the infertility community during a global pandemic. It also contributes to sociological discussions on the support mechanisms available to those navigating infertility and the wider social management of uncertainty.


2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Austin D. Schirmer ◽  
Jennifer F. Kawwass ◽  
Eli Y. Adashi

Abstract The COVID-19 pandemic has claimed the lives of over one million people worldwide, and has affected all aspects of healthcare worldwide, including the delivery of care to patients with fertility-related diagnoses. In the United States, the response of US fertility clinics to the COVID-19 pandemic was coordinated by the American Society for Reproductive Medicine (ASRM). ASRM acted quickly to develop guidelines for limiting fertility treatment and clinic consultations during the early days of the pandemic, and then safely restarting fertility treatment. A survey of patients with fertility-related diagnoses who presented for care during the first months of the pandemic revealed that a majority of patients who presented for care during the early months of the pandemic experienced delayed or cancelled treatment cycles. Patients with infertility subsequently reported a desire to resume fertility care, but emphasized the importance of their clinic having policies and procedures in place to limit the risk of infection.


2010 ◽  
Vol 17 (1) ◽  
pp. 81-95 ◽  
Author(s):  
Nicolette Priaulx

AbstractIn view of developments in reproductive medicine, clinical mishaps in this domain are beginning to give rise to ‘injuries’ not easily accommodated within the English law of negligence. While ‘personal injury’ is typically understood as manifesting a deleterious ‘physical’ dimension, cases involving the negligent destruction of cryopreserved sperm, as recently litigated in Yearworth & Ors v Bristol NHS Trust (2009), and other media reported mishaps in fertility treatment do not straightforwardly possess this quality. Without modification, the traditional tortious conception of ‘personal injury’ in English law will not be able to address novel claims. Critically, however, nor do alternative modes of redress seem to offer ease of application. Focusing upon the controversial Yearworth case and exploring what is seen as an unpromising framing of loss, the note argues that there is now an urgent need to rethink what counts as ‘personal injury’. Arguing for the formal recognition of ‘reproductive injury’ as an independent head of damage in negligence, and illustrating the presence of judicial support for that approach, the comment suggests that in light of the difficult challenges that lie in the wake of Yearworth, such a development may be not only desirable but necessary.


2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
K Christiansen

Abstract Study question Should medical professionals working in fertility care have additional training on how to deliver bad news and provide emotional support to patients? Summary answer Medical professionals providing assisted reproduction treatments should be offered more training to better assist the emotional burden that accompanies the treatment as described by patients. What is known already Pursuing fertility treatment provides a large physical and medical burden on patients. Many patients describe going through IVF like having a second full time job, adding stress, anxiety and social pressure to an already difficult time of trying to conceive. As specialists in reproductive treatment the main focus is trying to assist patients in achieving a healthy pregnancy and baby. In recent years it’s become evident that the emotional aspect is equally important and often patients are left feeling that their emotions and concerns are dismissed by the very healthcare professionals that are trying to help them have a baby. Study design, size, duration This qualitative study recruited 100 women who have had received assisted reproductive treatment in the United Kingdom during 2020. An online survey was presented to women who fit the inclusion criteria and and recruitment ended when data saturation was reached. The survey design consisted of open-text qualitative answer format. Participants/materials, setting, methods Inclusion criteria were women aged between 24–45 years old who had an infertility diagnosis and received assisted reproductive treatment. A survey was presented to them to describe any negative communication they had from medical professionals, specifically what was said and how it made them feel. Main results and the role of chance The most frequent answers were “you’re still young” (26%), “just lose some weight” (18%) and “it only takes one” (10%). Additional information included in responses had a message of “don’t worry” (50%) and “just relax” (32%). 20 participants had experienced miscarriage and 8 of them had been told “at least you can get pregnant”. The emotional response that accompanied messages like these from their healthcare professionals included anger, frustration and discouragement from “feeling invalidated”, “my feelings don’t matter” and “feeling like my baby didn’t matter”. Limitations, reasons for caution As the results are based on qualitative data from 100 women, the results can not be readily generated to larger populations. Furthermore, the questionnaire was specifically focused on negative experiences and therefore bias would have occurred. The survey was only advertised on social media. Wider implications of the findings: Women undergoing fertility treatment commonly experience guilt, shame and lack of confidence. Given the question was open ended and similar responses were given, indicates that additional training in emotional support throughout treatment would be recommended and stresses the need to better integrate these aspects of patient care into daily practice. Trial registration number Not applicable


2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
L Schaler ◽  
L Glover ◽  
M Wingfield

Abstract Study question To investigate the attitudes of male and female fertility patients to risk mitigation strategies and pregnancy advice during the first wave of the COVID–19 pandemic. Summary answer The desire to conceive outweighed fears regarding infection. Patients felt fertility treatments should be classified as essential and were agreeable to most risk mitigation strategies. What is known already The effects of the COVID–19 global pandemic on fertility services became evident in early 2020. Because of possible impacts of the virus on gametes, embryos and patients and concerns over virus transmission and the ability of medical services to cope, fertility treatments were temporarily suspended, as advised by ESHRE, ASRM and others. Across Europe, services were paused for approximately 7 weeks. Patients have reported that they found this extremely stressful and in some cases, unfair. After the initial closures, many clinics re-opened but with new risk mitigation strategies regarding PPE, hygiene and reducing staff and patient footfall. Study design, size, duration Men and women with a scheduled appointment at a fertility clinic over a 7-week period during the first wave of the COVID–19 pandemic were asked to complete a questionnaire outlining their experience and how it affected them. Participants were recruited via email using a secure online patient portal. A standardised anonymous 25-item questionnaire was sent to 828 patients and a reminder was circulated seven days later. The questionnaire remained open for 28 days. Participants/materials, setting, methods Participants were invited to complete a questionnaire and assured that all data would remain anonymous. Three areas were assessed. Firstly, how the pandemic itself affected their attempts to conceive. Secondly, participant perceptions regarding the overall disruption to fertility services. Thirdly, how participants feel fertility services should be treated in the event of a future large scale global pandemic. Main results and the role of chance 135 responses were received, giving a response rate of 16.3%. 80% of respondents were female and 20% male with no significant difference in responses between the sexes. Most participants (96%) had completed third level education and 90% were fully employed. Interestingly, 69% of participants continued trying to conceive during this time. This was despite 28% having concerns about contracting COVID–19 should they attend a clinic, 21% having concerns regarding the effect of the virus on pregnancy and 21% having concerns regarding an impact on the fetus. The majority surveyed (93%) stated that fertility treatment should be considered essential. 90% had their treatment disrupted or altered and, of these, 44% felt that this was justified, 23% disagreed and 33% were unsure. Regarding changes implemented within the clinic, 68% were satisfied with online video consultations and a further 16% would be content in certain circumstances. 92% felt privacy was maintained and 95% were happy to sign consent forms via video link. Many disagreed with the no partner policy at early pregnancy scans(57%) and embryo transfer(44%); however, they agreed with it for phlebotomy and treatment scans. In the event of a future pandemic, 79% felt fertility services should or probably should be continued. Limitations, reasons for caution This study focuses on the first wave of COVID–19. The long term, ongoing nature of the pandemic may influence participants’ perspectives on the areas investigated over time. Wider implications of the findings: It is estimated that the world will face a global pandemic approximately once every generation. Fertility stakeholders must learn from these events and studies such as ours are important to ascertain the views of service users. Some policies, such as video consultations, may be of benefit even in non-pandemic times. Trial registration number Not applicable


Sign in / Sign up

Export Citation Format

Share Document